Hepatitis C, E and G Virus - Three New Viruses Identified by Molecular Biology Technique in the Last Decade

Annals of the Academy of Medicine Singapore

Volumn 26, Issue 5, 1997, Pages 682-686

  Chow, W C ^a   Ng, H S ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Prevalence; Singapore

Indexed keywords

WATER;

FLAVIVIRUS; FOOD CONTAMINATION; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN; ISOLATION AND PURIFICATION; REVIEW; SINGAPORE;

FLAVIVIRIDAE; FOOD CONTAMINATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS E VIRUS; HUMANS; SINGAPORE; WATER;

EID: 0031216764     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Choo Q L, Kuo G, Weiner A J, Overby L R, Bradley D W, Houghton M Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62
2. Tokita H, Okamoto H, Tsuda F, Song P, Nakata S, Chosa T, et al Hepatitis C variants from Vietnam are classifiable into the seventh, eighth and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91:11022-6.
3. Simmonds P, Alberti A, Alter H J, Bonino F, Bradley D W, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19:1321-4.
4. Smith D B, Pontisso P Heterogeneity of hepatitis C virus. In: Alberti A, editor. Bailhere's Clinical Gastroenterology. Cambridge: Bailliere Tindall, 1996; 10:243-55.
5. Houghton M, Weiner A, Han J, Kuo G, Choo Q L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral diseases. Hepatology 1991, 14:381-8.
6. Kao J H, Hwang Y T, Lai M Y, Chen P J, Shen J C, Wang T H, et al. Hepatitis C antibody and viral RNA profile in patients with chronic non-A, non-B hepatitis and the relationship to liver disease [abstract]. Hepatology 1993; 18(4 pt 2):238A
7. Booth J C L, Thomas H C. Pathogenesis of chronic hepatitis C and associated clinical manifestations In Alberti A, editor. Bailliere's Clinical Gastroenterology. Cambridge: Bailliere Tindall, 1996, 10:257-74
8. Kiyosawa K, Akhane Y, Nagata A, Koike Y, Firita S Significance of blood transfusion in non-A, non-B chronic liver disease in Japan Vox Sang 1982; 43:45-52.
9. Pozzato G, Kaneko S, Moretti M, Croce LS, Franzin F, Unoura M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43:291-6.
10. Silini E, Bono F, Cividii A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 1995; 21:285-90.
11. Booth J C, Foster G R, Kumar U, Galassim R, Goldin R D, Brown J L, et al. Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha Gut 1995; 36.427-32.
12. Pozzato G, Moretti M, Franzin F, Croce L S, Tiribelli C, Masayu T, et al Severity of liver disease with different HCV clones. Lancet 1991, 338:509
13. Chemello L, Cavalletto L, Noventa F, Bonetti, Casarin C, Bernardmello E, et al Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon Alfa J Viral Hepatol 1995; 2:91-6
14. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C Hepatology 1995; 22:1050-6
15. Mellor J, Walsch E A, Prescott L E, Jarvis L M, Davidson F, Yap P L, et al. Survey of type 6-group variants of hepatitis C virus in Southeast Asia using a core-based genotyping assay J Clin Microbiol 1996, 34:417-23.
16. Lee A S G, Ng K Y , Chee M K L, Vathsala A, Choong HL, Ng HS, et al Partial sequence analysis of the hepatitis C viral genome in Singapore patients. Biochem Biophys Res Commun 1994; 199:37-40.
17. Pawlotsky J M, Deforges L, Bretagne S, Andre C, Metreau J M, Thiers V, et al Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. Gut 1993, 34(2 suppl):S 66-8
18. Lenzi M, Johnson P J, McFarlane IG, Ballardini G, Smith H M, McFarlane B M, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991; 338:277-80.
19. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336:1400-3.
20. Lunel F Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 1994, 107:1550-5.
21. Chow W C, Ng H S, Leong S, Chong R, Lim C C, Lee A, et al. Autoimmune liver disease and hepatitis C [abstract] IXth Biennial Scientific Meeting of the Asian Pacific Association for the Study of the Liver; 1994 Jan 26-29; Kuala Lumpur, Malaysia, 1994:89
22. Mattson L, Grillner L, Weiland O Seroconversion to hepatitis C virus antibodies in patients with acute post-transfusion non-A, non-B hepatitis in Sweden with a second-generation test. Scand J Infect Dis 1992, 24:15-20
23. Pawlotsky J M, Lunel F, Zarski J P, Laurent-Puig P, Brechet C. Diagnostic biologique des infections par le virus de l'hepatiteC Gastroenterol Clin Biol 1996; 20:146-61
24. Quiroga J A, Campillo M L, Castillo I, Bartolome J, Porres J C, Carreno V. IgM antibody to hepatitis C virus in acute and chronichepatitis C. Hepatology 1991; 14:38-43.
25. Pawlotsky J M, Darthuy F, Remire J, Pellet C, Udm L, Stuyver L, et al Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 1995; 47:285-91.
26. Kitchen A D, Barbara A J. The development of tests for antibody to hepatitis C virus. In: Harrison T J, Zuckerman A J, editor The Molecular Medicine of Viral Hepatitis. England: John Wiley & Sons, 1997:141-52
27. Benhamou J P, Hopf U, Rizzetto M, Sachez-Tapias J M, Bracomer J H, Bunler H, et al. Long term lymphoblastoid interferon enhances sustained responses and improves histological activity up to 12 months post-treatment [abstract]. Hepatology 1995; 22(4 pt 2):151A.
28. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, et al A comparison of three interferon alfa-2b regimens for the long term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332:1457-62.
29. Reichard O, Norkrans G, Fryden A, Braconier J H, Alaeus A, Glaumonn H, et al. Interferon-alpha and ribavirin versus interferon-alpha alone as therapy for chronic hepatitis C - a randomised double-blind placebo-controlled study [abstract] Hepatology 1996; 24(4 pt 2) 356A
30. Balayan M S, Andjapandze A G, Savinskaya S S, Ketiladze E S, Braginsky D M, Sarinov A P, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route Intervirol 1983, 20:23-31.
31. Khuroo M S. Study of an epidemic of non-a, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type Am J Med 1980; 68:818-24.
32. Reyes G R, Purdy M A, Kim J P, Luk K C, Young L M, Fry K E, et al Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247:1335-9.
33. Zuckerman AJ. Hepatitis E virus: the mam cause of enterically transmitted non-A, non-B hepatitis BMJ 1990, 300 1475-6
34. Tsega E, Krawczyuski K, Hansson B G, Nordenfelt E, Negusse Y, Alemu W, et al. Outbreak of acute hepatitis E virus infection among military personnel in Northern Ethiopia. J Med Virol 1991; 34:232-6
35. Zaaijer H L, Yin M F, Lelie P N Seroprevalence of hepatitis E in the Netherlands. Lancet 1992, 340:681
36. Pham B N, Guigonis V, Durand F, Bemuau J, Udin L, Bezeaud A. Anti-HEV antibodies in acute hepatitis in France. J Hepatol 1994; 20:679.
37. Chow W C, Ng H S, Lim G K, Don C J Hepatitis E in Singapore - a seroprevalence study. Singapore Med J 1996; 37:579-81.
38. Oon C J. Hepatitis E in Singapore. Epidemiol News Bull (Singapore) 1992; 18:45-6.
39. Khuroo M S, Rustgi V K, Dawson G J, Mushahwar I K, Yattoo G N, Kamili S, et al. Spectrum of hepatitis E virus infection in India. J Med Virol 1994; 43:281-6.
40. Krawczynski K. Hepatitis E. Hepatology 1993; 17:932-41.
41. Chow WC, Lee A S G, Lim G K, Cheong W K, Chong R, Tan C K, et al Acute viral hepatitis E: clinical and serological studies in Singapore. J Clin Gastroenterol 1997, 24:235-8.
42. Clayson E T, Mymt K S A, Snitbhan R, Vaughn D W, Innis B L, Chan L, et al Viraemia, faecal shedding and IgM and IgG responses in patients with hepatitis E J Infect Dis 1995; 172:927-33.
43. Mushawar I, Dawson G J Hepatitis E virus: epidemiology, molecular biology and diagnosis. In: Harrison T J, Zuckerman A J, editor. The Molecular Medicine of Viral Hepatitis England: John Wiley & Sons, 1997.33-43.
44. Nanda S K, Ansari A H, Acharya S K, Jameel S, Panda S K. Protracted viraemia during acute sporadic hepatitis E virus infection. Gastroenterology 1995; 108:225-30.
45. Lau J Y, Sallie R, Fang J W, Yarbough P O, Reyes G R, Portmann B C, et al. Detection of hepatitis E virus genome and gene products in two patients with fulminant hepatitis E. J Hepatol 1995, 22:605-10.
46. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel A M. Reverse transcription-PCR detection of hepatitis virus. J Clin Microbiol 1996; 34:2660-4.
47. Heringlake S, Tillmann H L, Berger S, Schleuder G G, Mushahwar IK, Hunsmann, et al. Detection of GBV-CRNA in German patients with chronic viral hepatitis and in volunteers blood donors [abstract]. IX Triennial International Symposium on Viral Hepatitis and Liver Disease; 1996 Apr 21-25; Rome, Italy, 1996:259
48. Tagger A, Ribero M L, Atchou G, Azzario F, Cazzaniga G, Cilla V, et al. Detection of GB virus C sequence in Italian blood donors and patients and in African individuals [abstract]. IX Triennial International Symposium on Viral Hepatitis and Liver Disease; 1996 Apr 21-25; Rome, Italy, 1996:259.
49. Belli L S, Ideo G, Silini E. Hepatitis G virus and post-transplant hepatitis. N Engl J Med 1996, 335:1394-5.
50. Linnen J, Wages J, ZhangKeck Z Y, Fry K E, Krawczyuski K Z, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996, 271:505-8.
51. Jarvis L M, Davidson F, Hanley J P, Yap P L, Ludiam C A, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348:1352-5
52. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis N Engl J Med 1996: 334 1485-90.
53. Heringlake S, Osterkamp S, Trautwein C, Tillmann H L, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348:1626-9.
54. Alter H J. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334:1536-7.
55. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995, 346:1131-2
56. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996; 25 842-7.
57. Angus P, Moaven L, Scott Bowden D, Kim J, McCaw R, Gow P, et al. No apparent association of hepatitis G virus with non A-E fulminant hepatitis. J Gastroenterol Hepatol 1996, 11.A112.
58. Nishiguchi S, Tanaka M, Enomoto D, Minamitani S, Takeda T, Nakajima S, et al. Prevalence of GBVs among patients with fulminant non A-E hepatitis in Japan Gastroenterology 1996; 110(4):A1278
59. Kiyosawa K, Tanaka E, Kobayashi M, Ichijo T, Yoshizawa K, Sodeyama T, et al. Detection of HGBV RNA and HGV RNA in non-B, non-C chronic liver disease [abstract] IX Triennial International Symposium on Viral Hepatitis and Liver Disease; 1996 Apr 21-25; Rome, Italy, 1996:253